ADAM17-Mediated Reduction in CD14++CD16+ Monocytes ex vivo and Reduction in Intermediate Monocytes With Immune Paresis in Acute Pancreatitis and Acute Alcoholic Hepatitis (2019)
Attributed to:
Stat2 is a therapeutic target in liver inflammation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2019.01902
PubMed Identifier: 31507587
Publication URI: http://europepmc.org/abstract/MED/31507587
Type: Journal Article/Review
Parent Publication: Frontiers in Immunology
ISSN: 1664-3224